25 unchanged sentences
If our product candidates are not successfully developed and approved, we may never generate any product revenue.
−Removed: Our net loss was $17.2 million for the three months ended June 30, 2024.
−Removed: As of June 30, 2024, we had an accumulated deficit of $377.5 million.
+Added: Our net loss was $16.7 million for the three months ended September 30, 2024.
+Added: As of September 30, 2024, we had an accumulated deficit of $394.2 million.
We expect to continue to incur losses for the foreseeable future, and we anticipate these losses will increase substantially as WTX-124 and WTX-330 advance through development, and any future product candidates advance through preclinical studies and into and through clinical trials, and as we expand our clinical, regulatory, quality and manufacturing capabilities and incur additional costs associated with operating as a public company.
34 unchanged sentences
Some of these expenses may be incurred in advance of marketing approval and could be substantial.
−Removed: As of June 30, 2024, we had cash and cash equivalents of $135.3 million.
−Removed: We expect that our cash and cash equivalents as of June 30, 2024 will allow us to complete the development of WTX-124 through dose escalation and expansion as a monotherapy or in combination with pembrolizumab and the development of WTX-330 through dose escalation and expansion as a monotherapy.
+Added: As of September 30, 2024, we had cash and cash equivalents of $122.8 million.
+Added: We expect that our cash and cash equivalents as of September 30, 2024 will allow us to complete the development of WTX-124 through dose escalation and expansion as a monotherapy or in combination with pembrolizumab and the development of WTX-330 through dose escalation and expansion as a monotherapy.
Our cash and cash equivalents will not be sufficient to complete development of WTX-124, WTX-330 or any other product candidate.
1269 unchanged sentences
Some of the provisions of these laws may apply to our business activities.
−Removed: There are also states that are strongly considering or have already passed comprehensive privacy laws during the 2023 legislative sessions that will go into effect in 2024 and beyond, including New Hampshire and New Jersey.
+Added: There are also states that are strongly considering or have already passed comprehensive privacy laws that take effect in 2024 and beyond, including New Hampshire and New Jersey.
Other states will be considering these laws in the future, and Congress has also been debating passing a federal privacy law.
86 unchanged sentences
We expect to grow our organization, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.
−Removed: As of June 30, 2024, we had 45 employees.
+Added: As of September 30, 2024, we had 45 employees.
We expect to experience significant growth in the number of our employees and the scope of our operations, particularly in the areas of clinical development, regulatory affairs, finance and, if any of our product candidates receive marketing approval, sales, marketing and distribution.
86 unchanged sentences
Our stock price is likely be volatile.
−Removed: For example, from January 1, 2023, until August 2, 2024, our stock price has ranged from $1.57 to $8.19.
+Added: For example, from January 1, 2023, until November 1, 2024, our stock price has ranged from $1.57 to $8.19.
The stock market in general and the market for biotechnology and pharmaceutical companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies.
131 unchanged sentences
These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers or employees, and increase the costs to such stockholders of bringing such a claim, either of which may discourage such lawsuits against us and our directors, officers and employees.
−Removed: If a court were to find the either exclusive forum provision contained in our restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in other jurisdictions, all of which could materially adversely affect our business, financial condition and operating results.
+Added: If a court were to find either exclusive forum provision contained in our restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in other jurisdictions, all of which could materially adversely affect our business, financial condition and operating results.
Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 5, 2021, File No.
Second Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 27, 2023).
−Removed: Form of Common Stock Purchase Warrant.
−Removed: Loan and Security Agreement, dated as of May 2, 2024, by and among the Registrant, each other person party thereto as a borrower from time to time, each person party thereto as a guarantor from time to time, the lenders from time to time party thereto, K2 HealthVentures LLC, as administrative agent for the lenders, and Ankura Trust Company LLC, as administrative agent.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
WEREWOLF THERAPEUTICS, INC.
−Removed: August 8, 2024 By:
+Added: November 7, 2024 By:
/s/ Timothy W.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.